+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Radium-223"

Systemic Radiotherapy - Global Strategic Business Report - Product Thumbnail Image

Systemic Radiotherapy - Global Strategic Business Report

  • Report
  • March 2025
  • 93 Pages
  • Global
From
Alpha Emitters - Global Strategic Business Report - Product Thumbnail Image

Alpha Emitters - Global Strategic Business Report

  • Report
  • March 2025
  • 179 Pages
  • Global
From
Nuclear Medicine Radioisotopes Global Market Report 2024 - Product Thumbnail Image

Nuclear Medicine Radioisotopes Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Radiopharmaceutical Theranostics Market Report 2025 - Product Thumbnail Image

Radiopharmaceutical Theranostics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Radiotheranostics Market Report 2025 - Product Thumbnail Image

Radiotheranostics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Radium-223 is a radioactive isotope of radium used in nuclear medicine and radiopharmacology. It is used to treat prostate cancer that has spread to the bones, as it emits alpha particles that can kill cancer cells while sparing healthy tissue. Radium-223 is administered intravenously and is typically used in combination with other treatments such as hormone therapy. Radium-223 is produced in nuclear reactors and is available in a variety of formulations. It is typically supplied as a solution in a vial, which is then further diluted for administration. The shelf life of the product is typically short, and it must be stored and handled in accordance with safety regulations. The market for Radium-223 is relatively small, but it is growing as the demand for treatments for prostate cancer increases. Companies in the market include Algeta, Bayer, and Advanced Accelerator Applications. Show Less Read more